ClinicalTrials.Veeva

Menu

PICC Inserted by a Nurse-led Vascular Access Team in Poland (NIce-PICC)

M

Medical University of Warsaw

Status

Enrolling

Conditions

Vascular Access
PICC Line Placement

Treatments

Procedure: PICC placement

Study type

Observational

Funder types

Other

Identifiers

NCT06979128
KB/35/2025

Details and patient eligibility

About

Implantation of PICCs by a trained, dedicated nursing team can be effective and safe, and allows for intravenous therapy that requires medium- to long-term central venous access.

Full description

The insertion of Peripherally Inserted Central Catheters (PICCs) offers numerous advantages over direct puncture of central veins. Ultrasound-guided insertion of PICCs into the peripheral vein is characterized by the high efficiency and safety of the procedure as well as patient comfort, and is a safe alternative to centrally inserted central catheters (CICCs) associated with a lower risk of complications. The PICCs will be inserted into one of the veins of the arm (basilic, brachial, cephalic) under ultrasound guidance. Cannulation will be supervised by a physician. Prior to cannulation a local anesthetic drug will be applied to the site of the planned puncture. Each PICC cannulation set consists of an echogenic needle, a guidewire, an introducer, a catheter with a diameter of 4 or 5 Fr and a length of 50-60 cm, a adhesive sutureless fixation, a semi-permeable transparent dressing, a needleless connector and a sticker indicating the type of vascular access. During the procedure intracavitary ECG will be used to catheter tip navigation. After the procedure, a chest X-ray will be taken to document the correct position of the tip. Taking into account the experience of the researchers and the learning curve described in the literature, it is planned to perform 200 PICC insertion procedures during the study period (50 per operator).

Enrollment

200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age >18 years
  • Intravenous therapy with solutions requiring central vein cannulation (irritant drugs, extreme pH <5 and >9, osmolarity > 600 mOsm/l), e.g., chemotherapy, parenteral nutrition with osmolarity >900 mOsm/l
  • Difficult intravenous access with multiple blood collection
  • Ability to consent to participate in the study
  • Consent to participate in the study

Exclusion criteria

  • Presence of central venous catheter, such as. centrally inserted central catheter or totally implanted vascular device
  • Indication of another type of vascular access device
  • Lack of veins suitable for cannulation of the arm
  • Infection, burns or other skin lesion on the upper extremities (involving the site of planned catheter insertion and attachment)
  • Pregnancy (confirmed by history and review of medical records or confirmed by positive human chorionic gonadotropin (hCG) determination in urine or plasma)
  • Lack of patient consent to participate in the study
  • Lack of capacity to consent to participate in the study
  • No physician present to supervise the procedure

Trial design

200 participants in 1 patient group

Patients who requrie a PICC
Description:
All subjects patients who requrie a PICC
Treatment:
Procedure: PICC placement

Trial contacts and locations

1

Loading...

Central trial contact

Dr Maciej Latos

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems